Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Lathosterolosis is an extremely rare inborn error of sterol biosynthesis characterized by facial dysmorphism, congenital anomalies (including limb and kidney anomalies), failure to thrive, developmental delay and liver disease.
Features include always present findings: Narrow forehead, Epicanthus, Elevated circulating lathosterol concentration, and Long philtrum and others; and common findings: Chiari type II malformation, Short nose, Horseshoe kidney, and 2-3 toe cutaneous syndactyly and others. 36 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Lab test results | 5 | Elevated circulating lathosterol concentration, Elevated circulating alkaline phosphatase concentration, Elevated circulating alanine aminotransferase concentration |
SC5D function has not been fully characterized.
Lathosterolosis is associated with mutations in the SC5D gene on chromosome 11.
Lathosterolosis should be suspected in individuals with the following clinical, laboratory, imaging, and family history findings.
Clinical findings
Global developmental delays
Intellectual disability
Microcephaly
No approved treatments are currently available for lathosterolosis. The disease remains an area of unmet medical need.
No clinical practice guidelines for lathosterolosis have been published. Evaluations Following Initial Diagnosis To establish the extent of disease and needs in an individual diagnosed with lathosterolosis, the evaluations summarized (if not performed as part of the evaluation that led to the diagnosis) are recommended. Table 4. Lathosterolosis: Recommended Evaluations Following Initial Diagnosis
To monitor existing manifestations, the individual's response to supportive care, and the emergence of new manifestations, the evaluations summarized in are recommended. Table 6. Lathosterolosis: Recommended Surveillance
1 clinical trial registered. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
2 publications have been identified in PubMed for lathosterolosis. Research spans Diagnostic / Biomarker (50%) and Basic Science / Preclinical (50%).
Yaeger JDW (2026). [PMID: 41538718](https://pubmed.ncbi.nlm.nih.gov/41538718/). *Journal of extracellular vesicles*. [Basic Science / Preclinical]
Westbye AB (2025). [PMID: 39566847](https://pubmed.ncbi.nlm.nih.gov/39566847/). *Journal of lipid research*. [Diagnostic / Biomarker]
Data assembled from 8 of 12 sources · Last updated Sep 18, 2026, 1:35 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Arms and legs | 4 | 2-3 toe cutaneous syndactyly, 2-4 toe cutaneous syndactyly, Postaxial hand polydactyly |
Digestive system | 2 | Liver scarring (fibrosis) (hepatic fibrosis), Intrahepatic cholestasis |
Bones and joints | 2 | Weak and brittle bones (osteoporosis), Butterfly vertebrae |
Eyes | 2 | Cataract, Ptosis |
Head and neck | 2 | Thick upper lip vermilion, Microcephaly |
Kidneys and urinary system | 1 | Horseshoe kidney |
Lathosterolosis is an ultra-rare disorder of cholesterol biosynthesis. To date, seven affected individuals have been reported [, , , , , , ]. Hence, the full phenotypic spectrum is unknown at present. However, developmental delay, intellectual disability, microcephaly, facial dysmorphisms, cataracts, digit anomalies, and liver involvement appear to be consistent features of this condition . The following description of the phenotypic features associated with this condition is based on the published case reports. Table 2. Lathosterolosis: Frequency of Select Features
Feature | Proportion of Persons w/Feature1 | Comment |
|---|---|---|
Global developmental delay/ intellectual disability | 6/6 | Mild to severe |
Microcephaly | 6/6 | — |
Hypotonia | 5/6 | — |
Dysmorphic facial features | 6/6 | Bitemporal narrowing, sloping forehead, epicanthal folds, ptosis, downslanting palpebral fissures, anteverted nares, broad nasal tip, long philtrum, high-arched palate, micrognathia |
Cataracts | 6/6 | — |
Digit anomalies | 6/6 | Postaxial polydactyly, toe syndactyly, /or clinodactyly |
Liver disease | 6/6 | Seven individuals with lathosterolosis have been described in the literature thus far. However, diagnosis was established based on histopathologic and molecular studies of a fetus aborted at 21 weeks' gestation . |
Source: GeneReviews — "Lathosterolosis"
Characteristic facial features, including bitemporal narrowing, sloping forehead, epicanthal folds, ptosis, downslanting palpebral fissures, anteverted nares, broad nasal tip, long philtrum, high-arched palate, and micrognathia (similar to individuals with Smith-Lemli-Opitz syndrome)
Cataracts
Digit anomalies (postaxial polydactyly, toe syndactyly)
Liver disease
Laboratory findings
Elevated liver enzymes (alanine aminotransferase, alkaline phosphatase, and gamma-glutamyl transferase)
Elevated lathosterol level on plasma sterol analysis
Source: GeneReviews — "Lathosterolosis"
Another autosomal recessive disorder of cholesterol biosynthesis, Smith-Lemli-Opitz syndrome (SLOS), closely resembles lathosterolosis. Developmental delay, microcephaly, characteristic facial dysmorphism (epicanthal folds, ptosis, broad nasal tip, anteverted nostrils, and long philtrum), 2-3 toe syndactyly, and postaxial polydactyly are common in both conditions. Growth restriction is reported in most individuals with SLOS; other variably associated features include cleft palate, congenital heart defects, and external female genitalia in individuals with a 46,XY karyotype. Although cataract and liver disease are very common in lathosterolosis, they are relatively less common in SLOS .
Source: GeneReviews — "Lathosterolosis"
Genetic testing for SC5D is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for lathosterolosis has been reported in the published literature.
System/Concern | Evaluation | Comment |
|---|---|---|
Development | Developmental assessment | To incl motor, adaptive, cognitive, speech-language eval; Eval for early intervention/ special education |
Eyes | Ophthalmology eval | To assess visual acuity for cataracts Liver |
Genetic counseling | By genetics professionals1 | To inform affected persons their families re nature, MOI, implications of lathosterolosis to facilitate medical personal decision making Family support |
resources | By clinicians, wider care team, family support organizations | Assessment of family social structure to determine need for:; Community or such as Parent to Parent; Social work involvement for parental support; Home nursing referral ALP = alkaline phosphatase; ALT = alanine aminotransferase; GGT = gamma-glutamyl transferase; MOI = mode of inheritance 1. |
Lathosterolosis: Treatment of Manifestations Manifestation/Concern | Treatment | Considerations/Other Developmental delay/ |
Intellectual disability | See . | — |
Cataracts | Treatment per ophthalmologist | Cataracts may appear after birth progress gradually. |
Digit anomalies | Treatment per orthopedist | — |
Liver disease | Treatment per hepatologist | Avoid hepatotoxic drugs. |
Genitourinary anomalies | Treatment per nephrologist /or urologist | Family/Community |
Source: GeneReviews — "Lathosterolosis"
1 trial found
Evaluation |
|---|
Frequency/Comment |
|---|
Intellectual disability | Monitor developmental milestones | At each visit throughout childhood; Neuropsychological testing using age-appropriate standardized assessment batteries; Standardized quality of life assessment tools for affected persons parents/caregivers |
Cataracts | Ophthalmology eval | Annually or more frequently for severe presentation |
Liver disease | Liver enzymes: ALT, ALP, GGT | At each visit; Liver ultrasound; FibroScan® |
Source: GeneReviews — "Lathosterolosis"
Phenotype severity distribution: 24 always present features, 11 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).